Gynakologische Endokrinologie is a pivotal journal published by SPRINGER HEIDELBERG, dedicated to advancing the fields of endocrinology, obstetrics, gynecology, reproductive medicine, and pediatrics. With an ISSN of 1610-2894, this journal serves as a valuable platform for researchers and practitioners to disseminate their findings and explore emerging trends and treatments in the realm of women's health and endocrine disorders. Though currently positioned in the Q4 quartile across relevant categories, its mission is to foster scholarly discourse that bridges gaps in knowledge and enhances clinical practices. With a commitment to quality research, it provides a forum for innovative studies and case reports that could influence future healthcare strategies. Positioned in Germany, Gynakologische Endokrinologie aims to cater to a global audience, enhancing knowledge and collaboration in critical areas impacting women's health and hormone-related conditions.

Fertility and Sterility is a prestigious peer-reviewed journal dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Published by Elsevier Science Inc, this journal has been a cornerstone of scientific discourse since its inception in 1950 and is set to continue its influential coverage of cutting-edge research until 2024. Boasting an impressive impact factor, Fertility and Sterility is ranked among the top-tier journals in its category, holding Q1 status in both Obstetrics and Gynecology and Reproductive Medicine. With Scopus rankings placing it in the 97th and 96th percentiles respectively, the publication serves as a vital resource for researchers, clinicians, and students who seek to advance their understanding of fertility issues and reproductive health. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and innovative solutions to the complex challenges in reproduction, empowering professionals and scholars to make meaningful contributions in their fields.

Reproduction, Fertility and Development, published by CSIRO Publishing, is a prestigious journal that has been at the forefront of research in the fields of reproductive science, developmental biology, and related disciplines since its inception in 1989. With an ISSN of 1031-3613 and an E-ISSN of 1448-5990, this journal serves as a vital platform for disseminating innovative findings and methodologies that advance our understanding of reproductive processes and development in a variety of organisms. The journal is indexed in prominent databases, exhibiting a solid standing with a Q3 quartile ranking in both Animal Science and Zoology and Biotechnology, and covering 2023 rankings in multiple related categories. Operating from Australia, Reproduction, Fertility and Development embraces a commitment to enriching scholarly communication and fostering collaborative research efforts. Its focus on high-quality, peer-reviewed articles makes it an essential resource for researchers, professionals, and students seeking to stay abreast of the latest advancements and pivotal discussions in reproductive medicine and developmental biology.

Reproduction and Fertility is a premier academic journal published by BIOSCIENTIFICA LTD, dedicated to advancing knowledge in the fields of reproductive sciences, obstetrics, gynecology, and related areas. Established with a focus on delivering high-quality research, this journal has quickly ascended in prominence, achieving a commendable Q2 ranking in multiple categories, including Embryology, Obstetrics and Gynecology, Reproductive Medicine, and Urology, as of 2023. With an E-ISSN of 2633-8386, Reproduction and Fertility aims to provide a valuable platform for researchers, professionals, and students alike, offering insights into the latest discoveries and innovations in reproductive health. Although currently not an open-access journal, it remains committed to disseminating important findings that can influence clinical practices and policy-making worldwide. Operating from its headquarters in Bristol, United Kingdom, the journal serves as an essential resource for anyone invested in understanding and improving reproductive health outcomes through rigorous academic research.

Human Fertility, published by Taylor & Francis Ltd, is a key academic journal that serves the dynamic fields of medicine, obstetrics and gynecology, and reproductive medicine. Established in 1998 and with converged content extending to 2024, the journal holds a notable Q2 ranking in its respective categories, highlighting its influence and scholarly contributions to current research and practice. With an ISSN of 1464-7273 and an E-ISSN of 1742-8149, it rigorously disseminates studies, reviews, and advancements in human fertility, particularly emphasizing evidence-based practices and innovative techniques. Despite its traditional subscription model, the journal remains vital for researchers, healthcare professionals, and students seeking to foster advancements in reproductive health. Its articles are pivotal in addressing the multifaceted challenges faced in reproductive health and guiding future research trajectories.

Reproductive Biology and Endocrinology, published by BMC, is a distinguished open-access journal established in 2003, catering to researchers and professionals in the interdisciplinary fields of reproductive biology, endocrinology, and related biomedical sciences. With a notable impact in 2023, the journal has achieved Q1 rankings in Obstetrics and Gynecology, Reproductive Medicine, and Endocrinology, alongside a Q2 ranking in Developmental Biology, establishing itself as a pivotal source of high-quality research and insights. The journal's commitment to freely accessible research promotes knowledge dissemination across its domains, which is crucial for advancing understanding of reproductive health and endocrine mechanisms. With a robust Scopus ranking showcasing its relevance—17th out of 209 in Obstetrics and Gynecology, and 8th out of 90 in Reproductive Medicine—it serves as an essential resource for academics and clinicians alike, facilitating innovative research and fostering collaboration within the global scientific community.

REPRODUCTION, published by BIOSCIENTIFICA LTD, stands at the forefront of research in the fields of reproductive and developmental biology. With a focus on advancing our understanding of reproductive health and mechanisms, the journal has garnered an impressive reputation, consistently ranking in the first quartile for key categories including Embryology, Endocrinology, Obstetrics and Gynecology, and Reproductive Medicine in 2023. Notably, it holds an esteemed position in the Scopus rankings, with high percentiles that reflect its significant impact in the scientific community. The journal is committed to open access, promoting the broad dissemination of high-quality research to facilitate innovative discoveries and interdisciplinary collaboration. Situated in the United Kingdom, REPRODUCTION serves as a vital resource for researchers, professionals, and students eager to contribute to the evolving landscape of reproductive sciences and related fields.

Clinical and Experimental Reproductive Medicine (CERM) is a premier journal dedicated to advancing the field of reproductive medicine. Published by the Korean Society of Reproductive Medicine, it aims to disseminate high-quality research and innovative clinical practices in reproductive health and medicine. With its Q3 ranking in reproductive medicine for 2023, CERM is positioned as a significant resource for researchers and practitioners seeking to stay current with the latest developments and findings in the field. Since its inception in 2011, CERM has provided a vital platform for original research articles, review papers, and case studies that cover a range of topics, including fertility treatments, reproductive endocrinology, and embryology. Researchers benefit from its accessibility, inspiring new insights and evidence-based approaches to clinical practices. Based in South Korea, its rigorous peer-reviewed publication process ensures that all contributions meet high academic standards, making it an invaluable asset for anyone engaged in reproductive health research or practice.

Andrology, an esteemed journal published by WILEY, is dedicated to advancing the field of reproductive health and medicine. With an ISSN of 2047-2919, this journal spans critical topics in andrology, urology, and endocrinology, reflecting its strong commitment to scholarly excellence and innovation. As a Q1 ranked journal in both Reproductive Medicine and Urology, Andrology boasts impressive Scopus rankings, standing at 6th in Reproductive Medicine and 8th in Urology, placing it in the top 10% of its field. The journal is accessible as an Open Access platform, ensuring that valuable research findings are available to a broader audience. With significant impact evidenced by its categorization in Q2 for Endocrinology and Diabetes and Metabolism, Andrology serves as an essential resource for researchers, clinicians, and students alike, supporting the continued advancement of knowledge and practice in male reproductive health.

GYNECOLOGICAL ENDOCRINOLOGY is a prestigious open-access journal published by Taylor & Francis Ltd, focusing on the dynamic fields of endocrinology, obstetrics, and gynecology. With its ISSN of 0951-3590 and E-ISSN of 1473-0766, this journal provides a vital platform for the dissemination of high-quality research and advancements in gynecological endocrinology since its inception in 1987. Notably, it attained an Open Access status in 2023, enhancing its reach and accessibility to researchers and practitioners worldwide. The journal is renowned for its rigorous peer-review process and holds significant standing with a Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Endocrinology, Diabetes, and Metabolism, as of 2023. It is indexed with commendable Scopus ranks in various medical domains, offering a reliable resource for current methodologies and future directions in gynecological health. With the growing emphasis on women's health and endocrinological research, GYNECOLOGICAL ENDOCRINOLOGY serves as an essential repository for innovative studies, clinical insights, and emerging therapeutic strategies, making it an invaluable resource for researchers, clinicians, and students alike.